Hideki Kanamaru

945 total citations
36 papers, 643 citations indexed

About

Hideki Kanamaru is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Hideki Kanamaru has authored 36 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Neurology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Hideki Kanamaru's work include Intracranial Aneurysms: Treatment and Complications (21 papers), Traumatic Brain Injury and Neurovascular Disturbances (9 papers) and Intracerebral and Subarachnoid Hemorrhage Research (8 papers). Hideki Kanamaru is often cited by papers focused on Intracranial Aneurysms: Treatment and Complications (21 papers), Traumatic Brain Injury and Neurovascular Disturbances (9 papers) and Intracerebral and Subarachnoid Hemorrhage Research (8 papers). Hideki Kanamaru collaborates with scholars based in Japan, United States and China. Hideki Kanamaru's co-authors include Hidenori Suzuki, Fumihiro Kawakita, Masato Shiba, Fumi Nakano, Hirofumi Nishikawa, Yoshinari Nakatsuka, Masashi Fujimoto, Takeshi Okada, Manabu Ito and Takehisa Ueno and has published in prestigious journals such as Circulation, Stroke and Free Radical Biology and Medicine.

In The Last Decade

Hideki Kanamaru

34 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Kanamaru Japan 15 372 125 113 93 89 36 643
Carolin Zimmermann Germany 15 138 0.4× 97 0.8× 99 0.9× 49 0.5× 109 1.2× 21 606
Fanfan Chen China 9 164 0.4× 186 1.5× 44 0.4× 79 0.8× 75 0.8× 41 585
Seung Hun Oh South Korea 12 100 0.3× 218 1.7× 33 0.3× 50 0.5× 44 0.5× 33 472
Hisashi Narai Japan 15 312 0.8× 120 1.0× 35 0.3× 76 0.8× 59 0.7× 47 580
Tao Chang China 14 62 0.2× 96 0.8× 43 0.4× 78 0.8× 51 0.6× 37 389
Yongtao Zheng China 16 325 0.9× 127 1.0× 199 1.8× 35 0.4× 62 0.7× 31 572
Haruka Miyata Japan 14 274 0.7× 93 0.7× 135 1.2× 81 0.9× 75 0.8× 52 519
Don H. Bark United States 11 320 0.9× 183 1.5× 78 0.7× 36 0.4× 89 1.0× 12 667
Paul Cherian United States 12 76 0.2× 144 1.2× 31 0.3× 63 0.7× 89 1.0× 18 539
Elena I. Liang Japan 7 439 1.2× 105 0.8× 239 2.1× 103 1.1× 72 0.8× 7 686

Countries citing papers authored by Hideki Kanamaru

Since Specialization
Citations

This map shows the geographic impact of Hideki Kanamaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Kanamaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Kanamaru more than expected).

Fields of papers citing papers by Hideki Kanamaru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Kanamaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Kanamaru. The network helps show where Hideki Kanamaru may publish in the future.

Co-authorship network of co-authors of Hideki Kanamaru

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Kanamaru. A scholar is included among the top collaborators of Hideki Kanamaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Kanamaru. Hideki Kanamaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kawakita, Fumihiro, et al.. (2025). Increased Plasma Levels of Thrombin-Cleaved Osteopontin in Patients with Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage. International Journal of Molecular Sciences. 26(6). 2781–2781.
3.
Yuan, Ye, Yutong Zhao, Jerry Flores, et al.. (2024). Mitochondrial ferritin upregulation by deferiprone reduced neuronal ferroptosis and improved neurological deficits via NDRG1/Yap pathway in a neonatal rat model of germinal matrix hemorrhage. Journal of Cerebral Blood Flow & Metabolism. 45(3). 510–527. 6 indexed citations
4.
Kanamaru, Hideki, Shiyi Zhu, Lei Huang, et al.. (2024). UDP-Glucose/P2Y14 Receptor Signaling Exacerbates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats. Stroke. 55(5). 1381–1392. 5 indexed citations
5.
Zhou, You, Lei Wu, Lei Huang, et al.. (2024). Inhibition of acid-sensing receptor GPR4 attenuates neuronal ferroptosis via RhoA/YAP signaling in a rat model of subarachnoid hemorrhage. Free Radical Biology and Medicine. 225. 333–345. 4 indexed citations
6.
Kanamaru, Hideki & Hidenori Suzuki. (2024). Therapeutic potential of stem cells in subarachnoid hemorrhage. Neural Regeneration Research. 20(4). 936–945. 3 indexed citations
7.
Chen, Xionghui, Xuying He, Feng Xu, et al.. (2023). Fractalkine Enhances Hematoma Resolution and Improves Neurological Function via CX3CR1/AMPK/PPARγ Pathway After GMH. Stroke. 54(9). 2420–2433. 19 indexed citations
8.
Guo, Yong, Yi Huang, Lei Huang, et al.. (2022). Role of Estrogen-Related Receptor γ and PGC-1α/SIRT3 Pathway in Early Brain Injury After Subarachnoid Hemorrhage. Neurotherapeutics. 20(3). 822–837. 10 indexed citations
9.
10.
Kanamaru, Hideki, et al.. (2021). Clarithromycin Ameliorates Early Brain Injury After Subarachnoid Hemorrhage via Suppressing Periostin-Related Pathways in Mice. Neurotherapeutics. 18(3). 1880–1890. 14 indexed citations
11.
Kanamaru, Hideki, Fumihiro Kawakita, Yoichi Miura, et al.. (2020). Prognostic factors varying with age in patients with aneurysmal subarachnoid hemorrhage. Journal of Clinical Neuroscience. 76. 118–125. 21 indexed citations
12.
Kanamaru, Hideki, Fumihiro Kawakita, Fumi Nakano, et al.. (2019). Plasma Periostin and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage. Neurotherapeutics. 16(2). 480–490. 24 indexed citations
13.
Suzuki, Hidenori & Hideki Kanamaru. (2019). Potential therapeutic molecular targets for blood-brain barrier disruption after subarachnoid hemorrhage. Neural Regeneration Research. 14(7). 1138–1138. 43 indexed citations
14.
Ishida, Fujimaro, Fumi Nakano, Fumihiro Kawakita, et al.. (2019). Machine Learning Analysis of Matricellular Proteins and Clinical Variables for Early Prediction of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage. Molecular Neurobiology. 56(10). 7128–7135. 40 indexed citations
15.
Nishikawa, Hirofumi, Fumi Nakano, Fumihiro Kawakita, et al.. (2018). Modified Citrus Pectin Prevents Blood-Brain Barrier Disruption in Mouse Subarachnoid Hemorrhage by Inhibiting Galectin-3. Stroke. 49(11). 2743–2751. 70 indexed citations
16.
Nakano, Fumi, Fumihiro Kawakita, Lei Liu, et al.. (2018). Anti-vasospastic Effects of Epidermal Growth Factor Receptor Inhibitors After Subarachnoid Hemorrhage in Mice. Molecular Neurobiology. 56(7). 4730–4740. 14 indexed citations
17.
Kanamaru, Hideki, et al.. (2016). Simultaneous Spinal and Intracranial Chronic Subdural Hematoma Cured by Craniotomy and Laminectomy: A Video Case Report. Case Reports in Neurology. 8(1). 72–77. 8 indexed citations
19.
Kanamaru, Hideki, Tetsu Satow, Sei Sugata, et al.. (2015). Risk factors of mechanical vasospasm caused by guiding catheter during neuroendovascular therapy. Journal of Neuroendovascular Therapy. 9(5). 233–237. 1 indexed citations
20.
Ueno, Takehisa, et al.. (2003). Urachal anomalies: ultrasonography and management. Journal of Pediatric Surgery. 38(8). 1203–1207. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026